The historical rank and industry rank for Fabino Enterprises's OCF Margin % or its related term are showing as below:
BOM:543444'
s OCF Margin % Range Over the Past 10 Years
Min: -45.2 Med: -1.49 Max: 32.47
Current: 0.9
During the past 8 years, the highest OCF Margin % of Fabino Enterprises was 32.47%. The lowest was -45.20%. And the median was -1.49%.
BOM:543444's OCF Margin % is ranked worse than 70.72% of 963
companies
in the Drug Manufacturers industry
Industry Median: 9.95
vs BOM:543444: 0.90
Fabino Enterprises OCF Margin % Related Terms
Fabino Enterprises OCF Margin % Historical Data
* Premium members only.
The historical data trend for Fabino Enterprises's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Fabino Enterprises's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fabino Enterprises OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Fabino Enterprises's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Fabino Enterprises's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fabino Enterprises (BOM:543444) has a OCF Margin % of 1.15% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Fabino Enterprises and its competitors. According to the industry distribution chart, Fabino Enterprises ranks #681 out of 963 companies in the Drug Manufacturers industry, placing it in the top 70.7%.
Is Fabino Enterprises' OCF Margin % too high?
Fabino Enterprises' current OCF Margin % is 1.15%. The Drug Manufacturers industry median OCF Margin % is 9.95. Fabino Enterprises' value of 1.15% is 88.4% below this industry median. Based on the distribution chart, Fabino Enterprises ranks #681 out of 963 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Fabino Enterprises has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Fabino Enterprises' OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Fabino Enterprises ranks #681 out of 963 companies for OCF Margin %. This places Fabino Enterprises in the lower half of its industry. The industry median OCF Margin % is 9.95. Fabino Enterprises' value of 1.15% is 88.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fabino Enterprises's current OCF Margin % of 1.15% is 88.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Fabino Enterprises and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fabino Enterprises's current OCF Margin % is 1.15%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fabino Enterprises stock overvalued right now?
Fabino Enterprises (BOM:543444) has a current OCF Margin % of 1.15%. The stock's GF Value™ is ₹37.57, compared to a current price of ₹20.31 — trading 45.9% below its estimated fair value. The current OCF Margin % is 1.15% and 88.4% below the Drug Manufacturers industry median of 9.95. Fabino Enterprises' overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Fabino Enterprises (BOM:543444), the current OCF Margin % is 1.15% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fabino Enterprises (BOM:543444) Overvalued in 2026?
Based on GuruFocus' analysis, Fabino Enterprises stock appears to be undervalued.
The current stock price of ₹20.31 is trading 45.9% below its estimated GF Value™ of ₹37.57.
Key valuation signals for BOM:543444:
OCF Margin %: 1.15%
GF Value™: ₹37.57 vs. price of ₹20.31 (45.9% below fair value)
Industry Position: 88.4% below the Drug Manufacturers median (#681 of 963)
No single metric tells the full story. See the BOM:543444 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fabino Enterprises Ltd formerly known as Fabino Life Sciences Ltd is a pharmaceutical company. It is engaged in manufacturing, marketing, trading and packing of pharmaceutical and other wellness-focused consumer products. It offers a wide range of allopathic, Food and wellness, Veterinary, Multi-vitamin and herbal products. The company currently supplies in Haryana, Delhi, parts of Punjab, Himachal Pradesh, Eastern Uttar Pradesh, Orissa, and Jharkhand, and parts of West Bengal, Andhra Pradesh, and Nepal.
68GF Score
Get the complete analysis for BOM:543444
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543444 has been successfully added to your 
